Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 06:38:11 UTC
Update Date2022-11-23 21:54:22 UTC
HMDB IDHMDB0249775
Secondary Accession NumbersNone
Metabolite Identification
Common NameCefroxadine
Description7-{[2-amino-2-(cyclohexa-1,4-dien-1-yl)-1-hydroxyethylidene]amino}-3-methoxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid belongs to the class of organic compounds known as cephalosporins. Cephalosporins are compounds containing a 1,2-thiazine fused to a 2-azetidinone to for a oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid moiety or a derivative thereof. Based on a literature review a significant number of articles have been published on 7-{[2-amino-2-(cyclohexa-1,4-dien-1-yl)-1-hydroxyethylidene]amino}-3-methoxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid. This compound has been identified in human blood as reported by (PMID: 31557052 ). Cefroxadine is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Cefroxadine is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
Synonyms
ValueSource
7-{[2-amino-2-(cyclohexa-1,4-dien-1-yl)-1-hydroxyethylidene]amino}-3-methoxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylateGenerator
Chemical FormulaC16H19N3O5S
Average Molecular Weight365.4
Monoisotopic Molecular Weight365.104541898
IUPAC Name7-[2-amino-2-(cyclohexa-1,4-dien-1-yl)acetamido]-3-methoxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
Traditional Name7-[2-amino-2-(cyclohexa-1,4-dien-1-yl)acetamido]-3-methoxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
CAS Registry NumberNot Available
SMILES
COC1=C(N2C(SC1)C(NC(=O)C(N)C1=CCC=CC1)C2=O)C(O)=O
InChI Identifier
InChI=1S/C16H19N3O5S/c1-24-9-7-25-15-11(14(21)19(15)12(9)16(22)23)18-13(20)10(17)8-5-3-2-4-6-8/h2-3,6,10-11,15H,4-5,7,17H2,1H3,(H,18,20)(H,22,23)
InChI KeyRDMOROXKXONCAL-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as cephalosporins. Cephalosporins are compounds containing a 1,2-thiazine fused to a 2-azetidinone to for a oxo-5-thia-1-azabicyclo[4.2.0]Oct-2-ene-2-carboxylic acid moiety or a derivative thereof.
KingdomOrganic compounds
Super ClassOrganoheterocyclic compounds
ClassLactams
Sub ClassBeta lactams
Direct ParentCephalosporins
Alternative Parents
Substituents
  • Cephalosporin
  • N-acyl-alpha amino acid or derivatives
  • Alpha-amino acid amide
  • Alpha-amino acid or derivatives
  • Meta-thiazine
  • Vinylogous ester
  • Tertiary carboxylic acid amide
  • Amino acid or derivatives
  • Amino acid
  • Azetidine
  • Carboxamide group
  • Secondary carboxylic acid amide
  • Thioether
  • Hemithioaminal
  • Carboxylic acid derivative
  • Carboxylic acid
  • Dialkylthioether
  • Monocarboxylic acid or derivatives
  • Azacycle
  • Organic nitrogen compound
  • Primary aliphatic amine
  • Organonitrogen compound
  • Organooxygen compound
  • Primary amine
  • Carbonyl group
  • Hydrocarbon derivative
  • Organic oxide
  • Amine
  • Organopnictogen compound
  • Organic oxygen compound
  • Aliphatic heteropolycyclic compound
Molecular FrameworkAliphatic heteropolycyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP0.65ALOGPS
logP-3.4ChemAxon
logS-2.6ALOGPS
pKa (Strongest Acidic)3.28ChemAxon
pKa (Strongest Basic)7.6ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count6ChemAxon
Hydrogen Donor Count3ChemAxon
Polar Surface Area121.96 ŲChemAxon
Rotatable Bond Count5ChemAxon
Refractivity94.51 m³·mol⁻¹ChemAxon
Polarizability36.59 ųChemAxon
Number of Rings3ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+182.68730932474
DeepCCS[M-H]-180.32930932474
DeepCCS[M-2H]-214.06630932474
DeepCCS[M+Na]+189.41530932474
AllCCS[M+H]+183.532859911
AllCCS[M+H-H2O]+180.932859911
AllCCS[M+NH4]+186.032859911
AllCCS[M+Na]+186.732859911
AllCCS[M-H]-181.232859911
AllCCS[M+Na-2H]-181.232859911
AllCCS[M+HCOO]-181.432859911

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
cefroxadineCOC1=C(N2C(SC1)C(NC(=O)C(N)C1=CCC=CC1)C2=O)C(O)=O3996.6Standard polar33892256
cefroxadineCOC1=C(N2C(SC1)C(NC(=O)C(N)C1=CCC=CC1)C2=O)C(O)=O2660.7Standard non polar33892256
cefroxadineCOC1=C(N2C(SC1)C(NC(=O)C(N)C1=CCC=CC1)C2=O)C(O)=O3218.4Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
cefroxadine,2TMS,isomer #1COC1=C(C(=O)O[Si](C)(C)C)N2C(=O)C(NC(=O)C(N[Si](C)(C)C)C3=CCC=CC3)C2SC13046.1Semi standard non polar33892256
cefroxadine,2TMS,isomer #1COC1=C(C(=O)O[Si](C)(C)C)N2C(=O)C(NC(=O)C(N[Si](C)(C)C)C3=CCC=CC3)C2SC12744.9Standard non polar33892256
cefroxadine,2TMS,isomer #1COC1=C(C(=O)O[Si](C)(C)C)N2C(=O)C(NC(=O)C(N[Si](C)(C)C)C3=CCC=CC3)C2SC14538.6Standard polar33892256
cefroxadine,2TMS,isomer #2COC1=C(C(=O)O[Si](C)(C)C)N2C(=O)C(N(C(=O)C(N)C3=CCC=CC3)[Si](C)(C)C)C2SC12878.6Semi standard non polar33892256
cefroxadine,2TMS,isomer #2COC1=C(C(=O)O[Si](C)(C)C)N2C(=O)C(N(C(=O)C(N)C3=CCC=CC3)[Si](C)(C)C)C2SC12741.3Standard non polar33892256
cefroxadine,2TMS,isomer #2COC1=C(C(=O)O[Si](C)(C)C)N2C(=O)C(N(C(=O)C(N)C3=CCC=CC3)[Si](C)(C)C)C2SC14891.7Standard polar33892256
cefroxadine,2TMS,isomer #3COC1=C(C(=O)O)N2C(=O)C(N(C(=O)C(N[Si](C)(C)C)C3=CCC=CC3)[Si](C)(C)C)C2SC12962.2Semi standard non polar33892256
cefroxadine,2TMS,isomer #3COC1=C(C(=O)O)N2C(=O)C(N(C(=O)C(N[Si](C)(C)C)C3=CCC=CC3)[Si](C)(C)C)C2SC12764.7Standard non polar33892256
cefroxadine,2TMS,isomer #3COC1=C(C(=O)O)N2C(=O)C(N(C(=O)C(N[Si](C)(C)C)C3=CCC=CC3)[Si](C)(C)C)C2SC14270.5Standard polar33892256
cefroxadine,2TMS,isomer #4COC1=C(C(=O)O)N2C(=O)C(NC(=O)C(C3=CCC=CC3)N([Si](C)(C)C)[Si](C)(C)C)C2SC13111.9Semi standard non polar33892256
cefroxadine,2TMS,isomer #4COC1=C(C(=O)O)N2C(=O)C(NC(=O)C(C3=CCC=CC3)N([Si](C)(C)C)[Si](C)(C)C)C2SC12817.9Standard non polar33892256
cefroxadine,2TMS,isomer #4COC1=C(C(=O)O)N2C(=O)C(NC(=O)C(C3=CCC=CC3)N([Si](C)(C)C)[Si](C)(C)C)C2SC14472.8Standard polar33892256
cefroxadine,3TMS,isomer #1COC1=C(C(=O)O[Si](C)(C)C)N2C(=O)C(N(C(=O)C(N[Si](C)(C)C)C3=CCC=CC3)[Si](C)(C)C)C2SC12937.6Semi standard non polar33892256
cefroxadine,3TMS,isomer #1COC1=C(C(=O)O[Si](C)(C)C)N2C(=O)C(N(C(=O)C(N[Si](C)(C)C)C3=CCC=CC3)[Si](C)(C)C)C2SC12806.2Standard non polar33892256
cefroxadine,3TMS,isomer #1COC1=C(C(=O)O[Si](C)(C)C)N2C(=O)C(N(C(=O)C(N[Si](C)(C)C)C3=CCC=CC3)[Si](C)(C)C)C2SC14060.4Standard polar33892256
cefroxadine,3TMS,isomer #2COC1=C(C(=O)O[Si](C)(C)C)N2C(=O)C(NC(=O)C(C3=CCC=CC3)N([Si](C)(C)C)[Si](C)(C)C)C2SC13061.7Semi standard non polar33892256
cefroxadine,3TMS,isomer #2COC1=C(C(=O)O[Si](C)(C)C)N2C(=O)C(NC(=O)C(C3=CCC=CC3)N([Si](C)(C)C)[Si](C)(C)C)C2SC12832.7Standard non polar33892256
cefroxadine,3TMS,isomer #2COC1=C(C(=O)O[Si](C)(C)C)N2C(=O)C(NC(=O)C(C3=CCC=CC3)N([Si](C)(C)C)[Si](C)(C)C)C2SC14314.5Standard polar33892256
cefroxadine,3TMS,isomer #3COC1=C(C(=O)O)N2C(=O)C(N(C(=O)C(C3=CCC=CC3)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C)C2SC13017.8Semi standard non polar33892256
cefroxadine,3TMS,isomer #3COC1=C(C(=O)O)N2C(=O)C(N(C(=O)C(C3=CCC=CC3)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C)C2SC12845.6Standard non polar33892256
cefroxadine,3TMS,isomer #3COC1=C(C(=O)O)N2C(=O)C(N(C(=O)C(C3=CCC=CC3)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C)C2SC14068.1Standard polar33892256
cefroxadine,4TMS,isomer #1COC1=C(C(=O)O[Si](C)(C)C)N2C(=O)C(N(C(=O)C(C3=CCC=CC3)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C)C2SC13026.4Semi standard non polar33892256
cefroxadine,4TMS,isomer #1COC1=C(C(=O)O[Si](C)(C)C)N2C(=O)C(N(C(=O)C(C3=CCC=CC3)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C)C2SC12871.4Standard non polar33892256
cefroxadine,4TMS,isomer #1COC1=C(C(=O)O[Si](C)(C)C)N2C(=O)C(N(C(=O)C(C3=CCC=CC3)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C)C2SC13854.4Standard polar33892256
cefroxadine,2TBDMS,isomer #1COC1=C(C(=O)O[Si](C)(C)C(C)(C)C)N2C(=O)C(NC(=O)C(N[Si](C)(C)C(C)(C)C)C3=CCC=CC3)C2SC13391.1Semi standard non polar33892256
cefroxadine,2TBDMS,isomer #1COC1=C(C(=O)O[Si](C)(C)C(C)(C)C)N2C(=O)C(NC(=O)C(N[Si](C)(C)C(C)(C)C)C3=CCC=CC3)C2SC13036.9Standard non polar33892256
cefroxadine,2TBDMS,isomer #1COC1=C(C(=O)O[Si](C)(C)C(C)(C)C)N2C(=O)C(NC(=O)C(N[Si](C)(C)C(C)(C)C)C3=CCC=CC3)C2SC14579.8Standard polar33892256
cefroxadine,2TBDMS,isomer #2COC1=C(C(=O)O[Si](C)(C)C(C)(C)C)N2C(=O)C(N(C(=O)C(N)C3=CCC=CC3)[Si](C)(C)C(C)(C)C)C2SC13270.4Semi standard non polar33892256
cefroxadine,2TBDMS,isomer #2COC1=C(C(=O)O[Si](C)(C)C(C)(C)C)N2C(=O)C(N(C(=O)C(N)C3=CCC=CC3)[Si](C)(C)C(C)(C)C)C2SC13030.0Standard non polar33892256
cefroxadine,2TBDMS,isomer #2COC1=C(C(=O)O[Si](C)(C)C(C)(C)C)N2C(=O)C(N(C(=O)C(N)C3=CCC=CC3)[Si](C)(C)C(C)(C)C)C2SC14864.4Standard polar33892256
cefroxadine,2TBDMS,isomer #3COC1=C(C(=O)O)N2C(=O)C(N(C(=O)C(N[Si](C)(C)C(C)(C)C)C3=CCC=CC3)[Si](C)(C)C(C)(C)C)C2SC13332.4Semi standard non polar33892256
cefroxadine,2TBDMS,isomer #3COC1=C(C(=O)O)N2C(=O)C(N(C(=O)C(N[Si](C)(C)C(C)(C)C)C3=CCC=CC3)[Si](C)(C)C(C)(C)C)C2SC13053.4Standard non polar33892256
cefroxadine,2TBDMS,isomer #3COC1=C(C(=O)O)N2C(=O)C(N(C(=O)C(N[Si](C)(C)C(C)(C)C)C3=CCC=CC3)[Si](C)(C)C(C)(C)C)C2SC14325.7Standard polar33892256
cefroxadine,2TBDMS,isomer #4COC1=C(C(=O)O)N2C(=O)C(NC(=O)C(C3=CCC=CC3)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C2SC13445.3Semi standard non polar33892256
cefroxadine,2TBDMS,isomer #4COC1=C(C(=O)O)N2C(=O)C(NC(=O)C(C3=CCC=CC3)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C2SC13070.9Standard non polar33892256
cefroxadine,2TBDMS,isomer #4COC1=C(C(=O)O)N2C(=O)C(NC(=O)C(C3=CCC=CC3)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C2SC14473.5Standard polar33892256
cefroxadine,3TBDMS,isomer #1COC1=C(C(=O)O[Si](C)(C)C(C)(C)C)N2C(=O)C(N(C(=O)C(N[Si](C)(C)C(C)(C)C)C3=CCC=CC3)[Si](C)(C)C(C)(C)C)C2SC13467.9Semi standard non polar33892256
cefroxadine,3TBDMS,isomer #1COC1=C(C(=O)O[Si](C)(C)C(C)(C)C)N2C(=O)C(N(C(=O)C(N[Si](C)(C)C(C)(C)C)C3=CCC=CC3)[Si](C)(C)C(C)(C)C)C2SC13228.3Standard non polar33892256
cefroxadine,3TBDMS,isomer #1COC1=C(C(=O)O[Si](C)(C)C(C)(C)C)N2C(=O)C(N(C(=O)C(N[Si](C)(C)C(C)(C)C)C3=CCC=CC3)[Si](C)(C)C(C)(C)C)C2SC14186.7Standard polar33892256
cefroxadine,3TBDMS,isomer #2COC1=C(C(=O)O[Si](C)(C)C(C)(C)C)N2C(=O)C(NC(=O)C(C3=CCC=CC3)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C2SC13600.0Semi standard non polar33892256
cefroxadine,3TBDMS,isomer #2COC1=C(C(=O)O[Si](C)(C)C(C)(C)C)N2C(=O)C(NC(=O)C(C3=CCC=CC3)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C2SC13233.0Standard non polar33892256
cefroxadine,3TBDMS,isomer #2COC1=C(C(=O)O[Si](C)(C)C(C)(C)C)N2C(=O)C(NC(=O)C(C3=CCC=CC3)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C2SC14374.7Standard polar33892256
cefroxadine,3TBDMS,isomer #3COC1=C(C(=O)O)N2C(=O)C(N(C(=O)C(C3=CCC=CC3)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C2SC13556.6Semi standard non polar33892256
cefroxadine,3TBDMS,isomer #3COC1=C(C(=O)O)N2C(=O)C(N(C(=O)C(C3=CCC=CC3)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C2SC13248.2Standard non polar33892256
cefroxadine,3TBDMS,isomer #3COC1=C(C(=O)O)N2C(=O)C(N(C(=O)C(C3=CCC=CC3)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C2SC14173.7Standard polar33892256
cefroxadine,4TBDMS,isomer #1COC1=C(C(=O)O[Si](C)(C)C(C)(C)C)N2C(=O)C(N(C(=O)C(C3=CCC=CC3)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C2SC13723.7Semi standard non polar33892256
cefroxadine,4TBDMS,isomer #1COC1=C(C(=O)O[Si](C)(C)C(C)(C)C)N2C(=O)C(N(C(=O)C(C3=CCC=CC3)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C2SC13430.8Standard non polar33892256
cefroxadine,4TBDMS,isomer #1COC1=C(C(=O)O[Si](C)(C)C(C)(C)C)N2C(=O)C(N(C(=O)C(C3=CCC=CC3)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C2SC13991.8Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Cefroxadine GC-MS (Non-derivatized) - 70eV, Positivesplash10-0a4i-2900000000-03a6b71e5f2f34be381d2021-09-24Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Cefroxadine GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Cefroxadine GC-MS (TMS_1_1) - 70eV, PositiveNot Available2021-11-03Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Cefroxadine GC-MS (TMS_1_2) - 70eV, PositiveNot Available2021-11-03Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Cefroxadine GC-MS (TMS_1_3) - 70eV, PositiveNot Available2021-11-03Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Cefroxadine GC-MS (TBDMS_1_1) - 70eV, PositiveNot Available2021-11-03Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Cefroxadine GC-MS (TBDMS_1_2) - 70eV, PositiveNot Available2021-11-03Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Cefroxadine GC-MS (TBDMS_1_3) - 70eV, PositiveNot Available2021-11-03Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Cefroxadine 10V, Positive-QTOFsplash10-0002-0029000000-2bfd58a12e28b55838fe2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Cefroxadine 20V, Positive-QTOFsplash10-05cs-2945000000-30ce25f1b408b240d0772021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Cefroxadine 40V, Positive-QTOFsplash10-052f-9712000000-9da604c51c7f54c4e2692021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Cefroxadine 10V, Negative-QTOFsplash10-001i-0009000000-94f9c3f283ae621e07ac2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Cefroxadine 20V, Negative-QTOFsplash10-03yi-3579000000-1753fc96f4f631e623c42021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Cefroxadine 40V, Negative-QTOFsplash10-0006-9710000000-4bc8608a15a151bc30e42021-10-12Wishart LabView Spectrum

NMR Spectra

Spectrum TypeDescriptionDeposition DateSourceView
Predicted 1D NMR1H NMR Spectrum (1D, 100 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 100 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 1000 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 1000 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 200 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 200 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 300 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 300 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 400 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 400 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 500 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 500 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 600 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 600 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 700 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 700 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 800 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 800 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 900 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 900 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID2547
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound2647
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]